The Biobanking Market Set to Reach $12.38 Billion by 2031, Driven by Technological Innovations
The Future of Biobanking: A $12.38 Billion Market by 2031
The biobanking market is on a transformative path as it forecasts a remarkable growth trajectory, set to reach $12.38 billion by 2031. According to Reports provided by MarketsandMarkets™, this growth is anticipated from a value of $8.09 billion in 2026, which translates to a compound annual growth rate (CAGR) of 8.9% over the forecast period.
Key Drivers of Growth
Several factors contribute to the booming biobanking sector. The increasing integration of artificial intelligence, digital technologies, and automation in biobank management is pivotal. Add to this the growing requirement for energy-efficient ultra-low-temperature freezers, which plays a critical role in accelerating market expansion.
A significant driver is the expanding scope of cell and gene therapies. These innovative treatments necessitate the efficient collection, preservation, and management of high-quality biological samples. Biobanks serve as essential infrastructures that support sample storage, processing, tracking, and distribution, which are vital for research, clinical development, and therapeutic manufacturing. As the pipeline for these therapies continues to grow, the demand for advanced biobanking services and infrastructure is expected to escalate.
Market Segmentation and Insights
In 2025, the sample collection and storage segment dominated the biobanking landscape, holding the largest share due to the critical importance of maintaining sample integrity. The total market for biobanking can be segmented into sample collection and storage, sample processing, sample analysis, and transport logistics. This sector's growth is fueled by the increasing necessity for reliable infrastructure that assures high-quality biospecimen collection, preservation, and long-term storage.
Moreover, within the biobanking workflow, demand for automated equipment is projected to grow rapidly, enabling efficiencies and precision.
By user demographics, the pharmaceutical and biotechnology companies, along with contract research organizations (CROs), are expected to account for the highest growth in biobanking services. They increasingly rely on high-quality biological samples to drive innovation in drug development and other advanced therapies.
North America: The Dominant Market Leader
The North American region leads the way, capturing approximately 43.3% of the total biobanking market share in 2025. This dominance can be attributed to a well-established pharmaceutical and biotechnology ecosystem, significant investments in biomedical research, and an early adoption of innovative biobanking technologies. Key governmental support and institutional funding further solidify North America's position, catering to demands in oncology research, biomarker discovery, precision medicine, and more.
Strategic Investments and Innovations
As the landscape evolves, there is a noticeable trend of increased strategic investments across the biobanking market. This is evident from recent mergers and acquisitions aiming to bolster biospecimen management and enhance technological capabilities. For instance, the acquisition of UK Biocentre by Azenta significantly expanded European biorepository capabilities, highlighting the trend toward comprehensive sample management systems and advanced data interpretation technologies.
Furthermore, as the industry transitions from a traditional focus on physical storage and equipment to a more diversified revenue mix that includes consumables and outsourced sample management services, the competitive analysis reveals a landscape with significant opportunities for growth, innovation, and integration.
Conclusion
With the biobanking market on a steep ascent towards achieving a projected value of $12.38 billion by 2031, the synergies of technology, research, and strategic investment are undeniably shaping a future where biological sample management plays a crucial role in health care and drug development. Stakeholders in the industry must continue to embrace innovative solutions to meet the escalating demands for high-quality biological repositories, ensuring that they remain relevant and competitive in this rapidly evolving landscape.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.